{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:25:11Z","timestamp":1778624711632,"version":"3.51.4"},"reference-count":75,"publisher":"The Royal Society","issue":"1433","license":[{"start":{"date-parts":[[2003,5,29]],"date-time":"2003-05-29T00:00:00Z","timestamp":1054166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/royalsociety.org\/journals\/ethics-policies\/data-sharing-mining\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phil. Trans. R. Soc. Lond. B"],"published-print":{"date-parts":[[2003,5,29]]},"abstract":"<jats:p>\n                    Medical interest in glycolipids has been mainly directed to the rare and complex glycosphingolipid storage disorders that are principally caused by unitary deficiencies of lysosomal acid hydrolases. However, glycolipids are critical components of cell membranes and occur within newly described membrane domains known as lipid rafts. Glycolipids are components of important antigen systems and membrane receptors; they participate in intracellular signalling mechanisms and may be presented to the immune system in the context of the novel CD1 molecules present on T lymphocytes. A knowledge of their mechanism of action in the control of cell growth and survival as well as developmental pathways is likely to shed light on the pathogenesis of the glycosphingolipid storage disorders as well as the role of lipid second messengers in controlling cell mobility and in the mobilization of intracellular calcium stores (a biological role widely postulated particularly for the lysosphingolipid metabolite sphingosine 1\u2013phosphate). Other sphingolipid metabolites such as ceramide 1\u2013phosphate may be involved in apoptotic responses and in phagocytosis and synaptic vesicle formation. The extraordinary pharmaceutical success of enzymatic complementation for Gaucher's disease using macrophage\u2013targeted human glucocerebrosidase has focused further commercial interest in other glycolipid storage diseases: the cost of targeted enzyme therapy and its failure to restore lysosomal enzymatic deficiencies in the brain has also stimulated interest in the concept of substrate reduction therapy using diffusible inhibitory molecules. Successful clinical trials of the iminosugar\n                    <jats:italic>N<\/jats:italic>\n                    \u2013butyldeoxynojirimycin in type 1 Gaucher's disease prove the principle of substrate reduction therapy and have attracted attention to this therapeutic method. They will also foster important further experiments into the use of glycolipid synthesis inhibitors for the severe neuronopathic glycosphingolipidoses, for which no definitive treatment is otherwise available. Future glycolipid research in medicine will be directed to experiments that shed light on the role of sphingolipids in signalling pathways, and in the comprehensive characterization and their secretory products in relation to the molecular pathogenesis of the storage disorders; experiments of use to improve the efficiency of complementing enzymatic delivery to the lysosomal compartment of storage cells are also needed. Further systematic screening for inhibitory compounds with specific actions in the pathways of glycosphingolipid biosynthesis will undoubtedly lead to clinical trials in the neuronopathic storage disorders and to wider applications in the fields of immunity and cancer biology.\n                  <\/jats:p>","DOI":"10.1098\/rstb.2003.1270","type":"journal-article","created":{"date-parts":[[2003,9,9]],"date-time":"2003-09-09T11:27:32Z","timestamp":1063106852000},"page":"967-973","source":"Crossref","is-referenced-by-count":11,"title":["Future perspectives for glycolipid research in medicine"],"prefix":"10.1098","volume":"358","author":[{"given":"Timothy M.","family":"Cox","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"175","published-online":{"date-parts":[[2003,5,29]]},"reference":[{"key":"p_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(97)80034-0"},{"key":"p_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1273"},{"key":"p_3","unstructured":"Aghion E. 1934 La maladie de Gaucher dans l'enfance. Th\u00e8se Facult\u00e9 de M\u00e9dicin Paris."},{"key":"p_4","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/90.1.19"},{"key":"p_5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508103330608"},{"key":"p_6","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(97)80031-5"},{"key":"p_7","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1269"},{"key":"p_8","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(65)90743-6"},{"key":"p_9","doi-asserted-by":"publisher","DOI":"10.1007\/BF00711365"},{"key":"p_10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.082011999"},{"key":"p_11","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.Supplement_4.S298"},{"key":"p_12","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.30.10.981"},{"key":"p_13","unstructured":"Burton R. F. 1880 The Kasidah (couplets) of Haji Abdu El-Yezdi. London: Quaritch."},{"key":"p_14","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1278"},{"key":"p_15","unstructured":"Cavalli-Sforza L. L. & Bodmer W. F. 1971 The genetics of human populations. New York: Freeman."},{"key":"p_16","first-page":"106","article-title":"Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses","volume":"24","author":"Cox T. M.","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"p_17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02161-9"},{"key":"p_18","doi-asserted-by":"crossref","unstructured":"Ezekowitz R. A. B. & Gordon S. 1984 Attention of surface properties by macrophage activation. Expression of receptors for F c and mannose-terminal glycoproteins and differentiation antigens. In Contemporary topics in immunobiology vol. 18 (ed. D. O. Adams & Jr M. G. Hanna) pp. 33-56. New York: Plenum Press.","DOI":"10.1007\/978-1-4757-1445-6_2"},{"key":"p_19","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.1988.Supplement_9.6"},{"key":"p_20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.8.3560"},{"key":"p_21","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.71010366.x"},{"key":"p_22","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1267"},{"key":"p_23","doi-asserted-by":"crossref","unstructured":"Garrod A. E. 1908 The Croonian lectures on inborn errors of metabolism. Lancet ii 1-7.","DOI":"10.1016\/S0140-6736(01)78482-6"},{"key":"p_24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.3330.747"},{"key":"p_25","doi-asserted-by":"crossref","unstructured":"Garrod A. E. 1928 The lessons of rare maladies. Lancet i 1055-1060.","DOI":"10.1016\/S0140-6736(00)99941-0"},{"key":"p_26","unstructured":"Gaucher P. C. E. 1882 De l'\u00e9pith\u00e9lioma primitif de la rate. MD th\u00e8se Facult\u00e9 de M\u00e9dicine Paris."},{"key":"p_27","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1277"},{"key":"p_28","doi-asserted-by":"publisher","DOI":"10.1126\/science.3101176"},{"key":"p_29","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(00)88961-6"},{"key":"p_30","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1274"},{"key":"p_31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0021-9258(19)85263-8","article-title":"Inhibition of sphingolipid synthesis affects axonal outgrowth in hippocampal neurones","volume":"268","author":"Harel R.","year":"1993","journal-title":"J. Biol. Chem."},{"key":"p_32","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.1997.0137"},{"key":"p_33","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.153.2.429"},{"key":"p_34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0022-2275(20)38673-9","article-title":"Preparation of the active isomer of 1-phenyl-2 decanoyl-amino-3-morpholino-1- propanol, inhibitor of murine glucocerebroside synthetase","volume":"28","author":"Inokuchi J.-I.","year":"1987","journal-title":"J. Lipid Res."},{"key":"p_35","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/11.11.1775"},{"key":"p_36","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.58.070189.001521"},{"key":"p_37","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90147-3"},{"key":"p_38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1998.tb00138.x"},{"key":"p_39","doi-asserted-by":"publisher","DOI":"10.1126\/science.1069540"},{"key":"p_40","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(98)00117-5"},{"key":"p_41","doi-asserted-by":"publisher","DOI":"10.1078\/0171-2985-00089"},{"key":"p_42","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301593"},{"key":"p_43","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(96)00056-7"},{"key":"p_44","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(72)90381-6"},{"key":"p_45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0214530"},{"key":"p_46","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: upregulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran M. T.","year":"2000","journal-title":"Blood"},{"key":"p_47","unstructured":"Mourant A. E. Kopec A. C. & Domaniewska-Sobczak K. 1975 The distribution of the human blood groups and other biochemical polymorphisms 2nd edn. New York: Oxford University Press."},{"key":"p_48","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1271"},{"key":"p_49","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.11.1343"},{"key":"p_50","doi-asserted-by":"publisher","DOI":"10.1021\/bi00693a009"},{"key":"p_51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1982.tb07950.x"},{"key":"p_52","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(05)80010-8"},{"key":"p_53","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1275"},{"key":"p_54","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(00)12937-4"},{"key":"p_55","doi-asserted-by":"publisher","DOI":"10.4052\/tigg.7.495"},{"key":"p_56","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010335505357"},{"key":"p_57","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1279"},{"key":"p_58","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1268"},{"key":"p_59","unstructured":"Race R. R. & Sanger R. 1975 Blood groups in man 6th edn. Oxford: Blackwell."},{"key":"p_60","doi-asserted-by":"publisher","DOI":"10.1007\/BF00731489"},{"key":"p_61","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026796200760"},{"key":"p_62","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(81)72057-3"},{"key":"p_63","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198807000-00011"},{"key":"p_64","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8924(96)80999-8"},{"key":"p_65","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1265"},{"key":"p_66","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0021-9258(18)53324-X","article-title":"Ganglioside metabolism. Enzymology, topology and regulation","volume":"268","author":"Van Echten G.","year":"1993","journal-title":"J. Biol. Chem."},{"key":"p_67","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)00616-H"},{"key":"p_68","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1266"},{"key":"p_69","doi-asserted-by":"publisher","DOI":"10.1016\/0009-3084(80)90057-2"},{"key":"p_70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1998.tb00144.x"},{"key":"p_71","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1276"},{"key":"p_72","first-page":"141","article-title":"The Iysosomal localization of sphingolipid hydrolases","volume":"159","author":"Weinreb N. J.","year":"1968","journal-title":"Biochem. Biophys. Acta"},{"key":"p_73","unstructured":"Willis R. 1848 The works of William Harvey (translated ). London: Sydenham Society."},{"key":"p_74","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80183-X"},{"key":"p_75","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1272"}],"container-title":["Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rstb.2003.1270","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rstb.2003.1270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:27:41Z","timestamp":1778621261000},"score":1,"resource":{"primary":{"URL":"http:\/\/royalsocietypublishing.org\/rstb\/article\/358\/1433\/967-973\/20205"}},"subtitle":[],"editor":[{"given":"R. A.","family":"Dwek","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"T. D.","family":"Butters","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"F. M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"T. M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2003,5,29]]},"references-count":75,"journal-issue":{"issue":"1433","published-print":{"date-parts":[[2003,5,29]]}},"alternative-id":["10.1098\/rstb.2003.1270"],"URL":"https:\/\/doi.org\/10.1098\/rstb.2003.1270","relation":{},"ISSN":["0962-8436","1471-2970"],"issn-type":[{"value":"0962-8436","type":"print"},{"value":"1471-2970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,29]]}}}